Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kite Pharma Inc (NASDAQ:KITE)

50.74
Delayed Data
As of Jun 24
 -2.37 / -4.46%
Today’s Change
38.41
Today|||52-Week Range
89.84
-17.66%
Year-to-Date
Brexit Bargains: 3 Clinical-Stage Biotechs to Buy
Jun 24 / MotleyFool.com - Paid Partner Content
CAR-T Drugmakers: The Big Winners at ASCO This Year?
Jun 13 / MotleyFool.com - Paid Partner Content
Blame for Northwest Bio Collapse Lies With CEO, Not With Mythical 'Wolfpack'
Jun 23 / TheStreet.com - Paid Partner Content
My Favorite Clinical-Stage Biotech Stocks to Buy
Jun 11 / MotleyFool.com - Paid Partner Content
Could This Breakthrough Change Everything We Know About Treating Cancer?
Jun 18 / MotleyFool.com - Paid Partner Content
Cancer therapy re-engineers cells to hunt and destroy
Jun 02 / FT.com - Paid Partner Content

Today’s Trading

Previous close53.11
Today’s open50.44
Day’s range49.86 - 52.47
Volume1,334,757
Average volume (3 months)935,867
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-21.99%
Earnings growth (this year)-143.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales155.81
Price/Book4.04

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-0.87-3.68%
XONIntrexon Corp-1.20-4.76%
OPHTOphthotech Corp-3.89-6.96%
NVAXNovavax Inc-0.25-3.62%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$1.22
Annual revenue (last year)$17.3M
Annual profit (last year)-$101.7M
Net profit margin-589.02%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Arie S. Belldegrun
Chief Operating Officer
Cynthia M. Butitta
Corporate headquarters
Santa Monica, California

Forecasts

Partner Offers

Search for Jobs